German billionaire entrepeneur Adolf Merckle, whose generics firm Ratiopharm is to be sold to cover mounting debts, has taken his own life, his family has said.
In a statement, Mr Merckle's wife and children said that helplessness in the face of the financial crisis had "broken" the industrialist. He was hit by a train near his home in Blaubeurne on the evening of January 5.
Mr Merckle's drug empire, which also includes Germany's biggest drug wholesaler Phoenix Pharmahandel, is to be offered as collateral on a loan extension from 40 banks that he was unable to repay on time at the end of last year as his VEM empire had amassed a reported 5.0 billion euros in debts ($6.81 billion). The entrepeneur lost out heavily by short-selling stock in car-maker Volkswagen, along with a series of highly-leveraged acquisitions in recent years.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze